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ABSTRACT
Breast cancer is the most common cancer in women, and hundreds of thousands of unneces-
sary biopsies are done around the world at a tremendous cost. It is crucial to reduce the rate
of biopsies that turn out to be benign tissue. In this study, we build deep neural networks
(DNNs) to classify biopsied lesions as being either malignant or benign, with the goal of
using these networks as second readers serving radiologists to further reduce the number of
false positive findings. We enhance the performance of DNNs that are trained to learn from
small image patches by integrating global context provided in the form of saliency maps
learned from the entire image into their reasoning, similar to how radiologists consider global
context when evaluating areas of interest. Our experiments are conducted on a dataset of
229,426 screening mammography exams from 141,473 patients. We achieve an AUC of 0.8
on a test set consisting of 464 benign and 136 malignant lesions.
KEYWORDS: Breast cancer, deep neural networks, screening mammography, global con-
text, local patterns.
INTRODUCTION
Breast cancer is the most common cancer in women worldwide, after skin cancers and
about 42,170 women will die from breast cancer in the United States for 2020, according
to The American Cancer Society’s estimate [1]. Screening mammography, a low-dose X-
ray examination, is typically used for early detection of breast cancer. The United States
Preventive Services Task Force suggests women urdergo such exams every two years if they
are 50 to 74 years old and are at average risk for breast cancer [2]. Although multiple studies
have demonstrated that screening mammography reduces breast cancer mortality [3, 4, 2, 5],
performance benchmarks demonstrate that 10% of the performed exams are recalled for
additional imaging, and approximately 80% of biopsies subsequently performed are benign [6].
The yearly national cost of breast-care caused by the false positive mammograms is estimated
to be several billion of dollars [7, 8] and for women with a false positive diagnosis, their
mean cost of breast-care is even higher than the cost of breast-care services for women with
cancer [9]. It is therefore an important task to reduce the recall and biopsy rates so that to
decrease patients’ anxiety and reduce healthcare costs while still maintaining optimal cancer
detection rates, according to relevant guidelines [4].
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Traditional computer-aided detection (CAD) tools for mammography neither detected more
breast cancers nor decreased the recall rates for additional imaging [10, 11]. Early studies used
deep neural networks (DNNs) to assist radiologists interpreting screening mammograms by
making predictions for cancer of each breast [12, 13, 14, 15, 16, 17, 18]. This task is frequently
considered in literature. It can be viewed as breast-level classification, and models developed
accordingly have shown comparable performance to radiologists [16, 17, 18]. However, these
models suffer from performance degradation when evaluated on a population only containing
exams which lead to biopsies, without healthy breasts as negative cases [16]. Meanwhile,
models built for the breast-level classification task cannot provide independent risk estimations
for multiple areas of interests appearing in the same breast. It is common to encounter cases
with multiple findings [19]. For example, multiple bilateral circumscribed breast masses are
detected in approximately 1.7% of routine screening mammograms [20]. In the NYU Breast
Cancer Screening Dataset [21], a representative sample of screening mammograms from 2010
to 2017, there are 7.45% images with more than one annotated lesions, and 25.75% of these
images have lesions of different categories. Some examples are shown in Figure 1. In light of
this, the previously proposed models for breast-level classification are difficult to use for the
goal of reducing unnecessary biopsies.
a b
Figure 1. Images with both malignant lesion and benign tissue. a. An image of the left breast
from mediolateral oblique view (L-MLO). The breast has two lesions confirmed by biopsy,
one as malignant (annotated with red), and the other as benign (annotated with green). b. An
L-MLO mammogram image from another patient. There are two lesions on the image, one as
malignant (annotated with red), and the other as high-risk benign (annotated with yellow).
Besides breast-level malignancy classification, deep learning methods have also been
used to identify high-risk lesions [22, 23, 24, 25]. Some of these works can provide risk
estimation across regions of the breast, but usually only consider information in a small
local region [24, 25]. The majority of the existing works often utilize object detection
models such as Mask-RCNN [26], which neither explicitly utilize fine details nor consider
global context. In contrast, radiologists often consider global context factors to make their
diagnoses [27, 28]. These global context factors include the mammographic breast density,
i.e. the global amount of fibroglandular tissue, and the associated parenchymal and nodular
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patterns of the breasts [28]. Dense fibroglandular breast tissue is a known risk factor for breast
cancer [29]. Other global context factors include the distribution of microcalcifications in the
tissue adjacent to an index lesion, or throughout the breast. These global findings often affect
radiologists’ level of suspicion for a particular lesion. Within deep learning methodology,
these scenarios could be viewed as utilizing global image context for classifying a patch of an
image. This motivates investigating whether global context is as important for neural networks
as it is for human experts.
In this study, we consider lesion-level classification, and design models to directly dis-
tinguish biopsy-confirmed lesions as being either benign or malignant. With this strategy,
we enable the models to make accurate lesion-wise predictions. To show that deep learning
approaches can benefit from utilizing global image context in classifying local findings on
mammograms, we first train DNNs with cropped image patches to enable the learning of fine
details from a specific region, then integrate the extracted local information with the global
context. The global context is provided in the form of saliency maps (Figure 2) extracted by
a model classifying the entire image. Here we use Globally-Aware Multiple Instance Clas-
sifier [17] as the model to provide such saliency maps. In addition, we evaluate the models’
performance on a challenging population which consists only of cases that are difficult to
diagnose and the radiologist requested a biopsy for. This further differentiates our work from
previous works [16, 30, 17, 13, 18] and makes our results not directly comparable to theirs.
This is because these methods were developed and evaluated for the screening population,
which contains a lot of negative cases not requiring biopsy, which can inflate their evaluation
metrics [16].
Figure 2. An example of saliency maps. From left to right: a mammogram image of a right
breast from craniocaudal view view (R-CC) with an annotated malignant lesion, a saliency
map indicating suspicious regions for benign tissue, a saliency map indicating suspicious
regions for malignant lesions.
Our results show that DNNs trained with image patches can effectively decrease the number
of unnecessary biopsies, and that this ability can be further improved by utilizing global image
context. Our best model is able to distinguish between benign and malignant findings on a test
set of 600 lesions, achieving an area under the receiver operating characteristic curve (AUC) of
0.799±0.002. If the model is utilized to assist in reading mammograms, about 2% unnecessary
biopsies could be avoided while catching all malignancies, in addition to cases that radiologists
can easily exclude as benign or normal and not needing additional imaging. It reduces 15%
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more unnecessary biopsies than the model using only local information, when under the same
level of missed malignancies (2%). It is worth noting that these performance measurements are
computed on the population from which we exclude benign cases that radiologists can discount
confidently by reading mammograms or other imaging exams. Overall, our results strongly
suggest that the proposed strategy can be considered as a viable and valuable enhancer for
deep learning methods in reducing unnecessary biopsies based on screening mammography.
MATERIALS AND METHODS
This retrospective study was approved by our IRB and is compliant with the Health Insurance
Portability and Accountability Act. Informed consent was waived.
Data
We utilize a dataset consisting of 229,426 digital screening mammogramphy exams (1,001,093
images) from 141,473 unique patients screened between 2010 and 2017 [21]. Each exam has
four standard views and the resolution of images is approximately 2000×3000 pixels. We
asked fellowship-trained breast imagers to annotate both benign tissues (e.g. cyst, fibroade-
noma, fibrocystic change) and malignant lesions (e.g. IDC, ILC, DCIS), on the pixel-level.
In the entire dataset, there are 8842 lesions from 8080 images with diagnosis confirmed by
biopsy, which reveals the fact that a single breast can contain multiple lesions of differing
types. The dataset is divided into disjoint training (80%), validation (10%) and test (10%) sets.
Detailed statistics of training, validation and test sets are in Table 1.
Table 1. Number of biopsy-confirmed lesions and number of mammogram images presenting
no lesions, benign tissues, and malignant lesions in the training, validation and test set.
images lesions/tissues
negative benign malignant benign malignant
training 808,730 5,188 1,648 5,602 1,790
validation 123,130 687 110 722 128
test 60,959 432 116 464 136
overall 992,819 6,307 1,874 6,788 2,054
The proposed method
Lesions in mammograms vary in size and shape, so if we crop these regions entirely and
resize them to the same size to use them as inputs to standard deep neural networks, we will
introduce information distortion and lose the fine details of the lesions. Therefore, we start
by learning features of a number of image patches that are cropped from regions overlapping
with the lesion, and then aggregate information from all patches to render a prediction for that
lesion.
To extract information from image patches, we train a deep convolutional neural network
(DCNN) to classify image patches of 256×256 pixels as one of the four classes: “malignant”,
“benign”, “outside” and “negative.” Malignant and benign patches are cropped from windows
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that overlap with the segmentation of a malignant lesion or benign tissue. Besides cropping
image patches that overlap with the annotations, we sample patches that have no overlap with
any lesion (“outside”), as well as patches from breasts without records of biopsy (“negative”).
The inclusion of these additional data is intended to regularize the model similarly to data
augmentation. Examples of patches from each class are shown in Figure 3.
a b
c d
Figure 3. Examples of image patches along with the mammogram images from which they
come. a. “malignant” patches, which overlap only with malignant findings (marked with red);
b. “benign” patches, which overlap only with benign findings (marked with yellow or green);
c. “outside” patches, which are from regions outside the annotated lesions; d. “negative”
patches, which are from images without any biopsied findings.
This DCNN is used to produce representations of local information. It is denoted as
floc and is shown in Figure 4a. We use DenseNet-161 [31] as its architecture. We add an
additional fully-connected layer with 32 neurons between the global average pooling layer
and the classification layer to obtain concise representations of the patch. The additional layer
results in the feature vector h ∈ R32 for the patch, which we use as the representation for the
local information extracted by floc.
To further incorporate global image context and curate the local information extracted
by the DCNN, we train an “aggregation network” with inputs formed by aggregating maps
containing information relative to the patch and the image it is cropped from, as illustrated in
Figure 4b. This aggregation network is a shallow convolutional network, denoted as fagg. It
consists of two convolutional layers, each with 32 3×3 convolutional filters, a global average
pooling layer and, finally, a classification layer. We apply batch normalization and the ReLU
activation function prior to each convolutional layer. This network is trained for the same
patch classification task. The maps formed as inputs to the aggregation network are described
in the following paragraphs.
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The first type of maps are saliency maps which represent global context. We generate
the saliency maps by training a network on full-resolution mammography images to predict
the presence of benign and malignant lesions in the breast. We refer to this network as the
“context network.” We use Globally-Aware Multiple Instance Classifier [30, 17] as the context
network, which is explicitly designed to provide interpretability by highlighting the most
informative regions of the input images. To be more precise, the feature maps obtained after
the last residual block of the context network are transformed by a 1×1 convolutional layer
with sigmoid activation into two saliency maps, denoted as Sm ∈ [0,1]46,30 and Sb ∈ [0,1]46,30.
Each pixel in the saliency map corresponds to a region in the full image, and its element
denotes a score indicating the contribution of this region towards classifying the input image
as containing malignant lesions or benign tissues. A pair of saliency maps for an image is
shown in Figure 2.
Another type of maps are location indicator maps. Given a patch, this map indicates its
cropping window’s location on the mammogram, but is downscaled to be the same size as the
saliency maps. The location indicator map is denoted as I ∈ [0,1]46,30. Same with the saliency
maps, each pixel on the location indicator map corresponds to a region in the full image and
the value of this pixel reflects how much the region is covered by the patch.
The last type of maps, called embedding maps, are formed by utilizing the representation
h generated by floc. To construct this map, for each hk ∈ h, we take a copy of the location
indicator map of the patch I and replace its nonzero elements by hk. We denote the obtained
map byEk. We concatenateEk’s to form the full embedding mapE∈R46,30,32. The embedding
maps contain information learned by floc specific to the fine details in the image patch.
These maps can be concatenated along the last dimension and served as inputs to the
aggregation network, denoted as X ∈ R46,30,M where M is the number of maps. For example,
when using both embedding maps and saliency maps as inputs, M would be 34.
Model training
We first train floc that takes image patches as inputs, followed by the aggregation network
fagg, which takes the concatenated maps, X, as inputs. We use 20, 35, 5000, 4945 patches
for malignant, benign, outside and negative patch classes in each training epoch. For data
augmentation, we use random rotations (-30 to 30 degrees), and random sizes (128×128 to
384×384 pixels) when setting the cropping window to obtain the patch.
In order to address the extreme class imbalance, we use weighted cross-entropy as the
training loss. The class weight for each patch class is set as inverse to the ratio of patches from
this class among all patches used in each epoch. Therefore, losses on incorrect predictions of
“malignant” and “benign” patches are appropriately up-weighted. For both floc and fagg, we
adopt the same configuration while using 256×256 image patches as inputs for floc, and the
concatenated maps, X, as inputs for fagg, in which the embedding maps is produced by the
best performing floc and saved to be used.
We minimize the training loss with the Adam optimizer [32], setting the batch size to 25
for training floc, and 100 for fagg. We initialize weights in floc of all layers except the last
two fully connected layers with weights from DenseNet-161 [31] pretrained on the ImageNet
ILSVRC-2012 dataset [33], then fine-tune the entire network. We randomly initialized the
weights of fagg. We optimize the hyperparameters using random search [34]. Specifically, we
search for the learning rate on the logarithmic scale in [10−6,10−4] for floc, and in [10−5,10−3]
for fagg. Early stopping is performed if we observed that the AUC on the validation set has
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Figure 4. Illustration of the proposed method. Left: a deep convolutional neural network
which takes image patches of 256×256 pixels as inputs, denoted as floc. Right: the aggregation
network, fagg, that takes the concatenation of three types of maps as inputs: 1) location
indicator map, I, in gray, generated by downscaling the binary mask indicating the cropping
window’s location, 2) saliency maps, Sm and Sb, in red and green, generated by the context
network, based on Globally-Aware Multiple Instance Classifier [17], 3) embedding map, E, in
blue, formed by the representation h, produced by floc.
not increased for ten epochs. We implement the models in PyTorch [35], and use NVIDIA
Tesla V100 GPUs for model training and inference.
Model evaluation
During training, we consider patches from mammograms with and without lesions, and
perform multi-class classification over four classes: malignant, benign, outside and negative.
In the validation and test phases, we only consider patches from images with lesions, and
transform the patch-level predictions into a malignancy prediction for each lesion in the images.
To get a prediction for a lesion, as shown in Figure 5, we crop 100 patches that overlap with
the segmentation of the lesion. The size of the cropping window varies from 128×128 to
384×384 pixels, which is the same range we used for data augmentation. After cropping, each
patch is resized to 256×256 pixels, and we use it as input to floc to produce a feature vector.
Then, we apply fagg on the concatenated maps, including the embedding maps transformed by
the feature vector and we get its prediction, each as four scores for the four patch classes. For
each patch, we normalize the scores for malignant and benign patch classes so that they sum
to one. Finally, we average the 100 normalized scores of the 100 sampled patches to obtain a
prediction for the lesion. Based on these estimated probabilities, we compute the AUC that the
model achieves in classifying the lesions as malignant or benign. We use the AUC computed
on the 850 lesions from the validation set for model selection, and report the AUC computed
for the 600 lesions from the test set.
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Figure 5. Multiple patches are sampled to obtain a prediction for one lesion. In each black
box, we present a biopsied finding from the test set and ten out of 100 patches used by the
model to make a prediction for the finding. Lesions are marked in red (malignant) or green
(benign) and the cropping windows of the patches are marked by blue boxes on the image.
Cropped patches are shown on the right.
RESULTS
Model performance
We report the model’s performance on the test set consisting of 600 lesions which are present
on 534 images from 260 patients. There are 44 images containing more than one lesion, and
14 images have both benign and malignant lesions. We emphasize that if we were to use deep
learning methods that provide only breast-level risk estimation, it would be impossible to tell
which lesion is the one with higher risk of malignancy.
Both model components, floc, which takes patches as inputs, and the aggregation network
fagg, are selected according to their performance on the validation set. The best perform-
ing aggregation network using embedding maps and saliency maps achieved an AUC of
0.799±0.002 on the test set. In Table 2, we include more results on the portion of unnecessary
biopsies that can be avoided while missing a given portion of malignancies when using the
model’s prediction as a second reader to assist radiologists. It can help to further reduce
1.7% unnecessary biopsies in addition to cases that radiologists can easily exclude as benign
or normal and not needing additional imaging, while catching all malignancies. According
to the estimated yearly cost related with unnecessary biopsies [7, 8], it can be translated to
saving more than a million dollars each year in the US for breast-care. If reducing biopsies is
prioritized further, up to 13.5% could be avoided while only missing 1% of malignancies and
up to 23.1% could be avoided while only missing 2% of malignancies.
Ablation experiments
We conduct the following experiments to justify the choice of model architecture, to verify
impact of transfer learning, and to elaborate the importance of utilizing both local fine details
and global image context in identifying malignant lesions.
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Table 2. True negative rate (TNR) achieved by our model when its false negative rate (FNR)
are 0.01, 0.02, 0.03 and 0.05 as we vary prediction threshold for assigning observations to a
positive class indicating malignancy. The 95% confidence interval of the estimated TNR and
the clinical meaning are also provided.
clinical meaning FNR TNR 95% CI of TNR
1.7% unnecessary biopsies we can help to avoid
while missing no malignancies 0.00 0.017 [−0.005,0.040]
13.5% unnecessary biopsies we can help to avoid
while missing 1% malignancies 0.01 0.135 [0.039,0.232]
23.1% unnecessary biopsies we can help to avoid
while missing 2% malignancies 0.02 0.231 [0.190,0.273]
27.6% unnecessary biopsies we can help to avoid
while missing 3% malignancies 0.03 0.276 [0.240,0.312]
43.5% unnecessary biopsies we can help to avoid
while missing 5% malignancies 0.05 0.435 [0.407,0.562]
Architecture search. To choose the architecture for floc, we considered a number of
ResNet [36] and DenseNet [31] variants. These architectures use skip connections, which
improve information flow between layers, and allow for effective training of very deep
networks. They both achieved strong results across a wide range of image classification
tasks [37, 38, 39]. The specific ResNet and DenseNet variants we experimented with are:
ResNetV2-50, ResNetV2-101, ResNetV2-152, DenseNet-121, DenseNet-161, and DenseNet-
169. We compared the performance of floc when being parameterized as the above architec-
tures. The results are shown in Figure 6. In this experiment, we did not consider global context
and used the predictions made by floc for each lesion.
Transfer learning. Transfer learning by pretraining the network on a different task is widely
adopted to improve neural networks’ performance. We experiment with initializing floc
with weights from networks pretrained on the ImageNet ILSVRC-2012 dataset [33], and
compare it to initializing the weights randomly using He initialization [40]. Since images
from ImageNet are RGB while mammograms are grayscale, we duplicated each patch across
the three channels. The AUCs achieved by floc with or without using transfer learning are
presented in Figure 6. Without transfer learning, ResNetV2-50 achieved the highest AUC
of 0.762±0.015, while DenseNet-121 achieved the lowest AUC of 0.748±0.098. When we
applied transfer learning, the performance is improved for most of the architectures except
ResNetV2-152, and DenseNet-169 becomes the best performer with 0.782±0.014 AUC. We
conclude from these results that transfer learning from the ImageNet dataset [33] clearly
improves our results, even though the natural image domain and the mammography image
domain are so different.
Importance of global context. To assess the importance of global context in classifying
lesions localized to small regions of the image, we performed further ablation experiments.
We trained networks using different combinations of saliency maps, location indicator map
and embedding maps as inputs. Selected maps are concatenated along the last dimension
and used by the aggregation network. Table 3 presents the results when using all possible
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Figure 6. Test performance in classifying biopsied findings, achieved by floc, when using
different architectures and weights initialization strategies.
combinations. Since ImageNet-pretrained DenseNet-161 as floc achieved the highest AUC on
the validation set, we used it in this set of experiments.
As expected, for the task of classifying biopsy-confirmed lesions, most of the predictive
power comes from local features: the aggregation network trained with only embedding maps
achieved an AUC of 0.778±0.002. In comparison, the network trained only with saliency
maps achieved an AUC of 0.695±0.003, indicating that global context alone was not highly
predictive. When we introduced location indicator maps together with saliency maps into
the network, the AUC increased to 0.721±0.011. We observed that using location indicator
maps and embedding maps together does not improve performance. This is unsurprising since
embedding maps contain the same location information conveyed by the location indicator
maps. Finally, networks using the combination of embedding maps and saliency maps
achieved an AUC of 0.799±0.002, which is the highest among all combinations. The fact that
combining local features with global context outperformed each of them in isolation confirms
the importance of the global image context in classifying lesions localized to small regions of
the mammogram.
To further evaluate the impact of the global context in our task, we investigate the relation
between the true negative rate (indicating biopsies that can help to avoid) and the false negative
rate (indicating missed malignancies). Specifically, we compare the aggregation network using
only the ensemble maps and the aggregation network using both the ensemble maps and the
saliency maps. Figure 7 visualizes this relationship. We considered scenarios when there are
less than 5% malignancies missed. For all considered false negative rates utilizing the saliency
maps resulted in lower true negative rate.
DISCUSSION
Regular screening mammography is widely acknowledged to be the best way to detect breast
cancer early. However, mammogram-based diagnosis performed by radiologists suffers from a
high false positive rate, resulting in both unnecessary imaging and tissue biopsies. Developing
deep learning technologies to assist breast cancer screening is promising, but previous works in
the literature rarely focused on reducing unnecessary biopsies. Besides achieving radiologist-
level performance at detecting breast cancer in mammograms, deep learning models are
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Table 3. Test performance of the aggregation network when using different information
combinations as inputs. Models utilizing both local and global information achieved better
performance than the counterparts using single type of maps.
AUC
location indicator maps 0.474 ± 0.031
embedding maps 0.778 ± 0.002
saliency maps 0.695 ± 0.003
location indicator maps + embedding maps 0.777 ± 0.002
location indicator maps + saliency maps 0.721 ± 0.011
embedding maps + saliency maps 0.799 ± 0.002
location indicator maps + saliency maps + embedding maps 0.797 ± 0.001
0.00 0.01 0.02 0.03 0.04 0.05
rate of missing malignant biopsies (TNR)
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Figure 7. True negative rate (TNR) and false negative rate (FNR) achieved by the aggregation
network using ensemble maps or using both ensemble maps and saliency maps as we vary the
prediction threshold for assigning observations to a given class.
expected to play a more important role in distinguishing whether a given lesion is malignant or
benign. This distinction is highly beneficial for the case of suspicious-appearing but ultimately
benign findings that result in unnecessary biopsies by the radiologist.
In this study, we presented a method to combine local features in small image patches
with global context in high resolution mammogram images. We showed that it is necessary
to consider both fine details in a small region and the global image context to improve
deep learning models’ performance when classifying localized lesions on the high resolution
images, while previous works usually consider only image patches or downscaled mammogram
images [41, 42, 14]. Our resulting deep learning model achieved an AUC of 0.799±0.002
in classifying biopsy-confirmed lesions as being malignant or benign. It can help to further
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reduce over 23% of unnecessary biopsies while missing only 2% of cancer as the second reader
on regions that radiologists have low confidence on. Compared with works performing breast-
level classification [14, 16, 43, 41, 30, 17, 18], our model can provide prediction for each
individual suspicious lesion, and therefore present precise guidance for followup procedure
including biopsy and surgery.
We acknowledge some limitations of this work. For instance, we did not capture the
levels of difficulty related to different types of cancer, which is clinically valuable. We leave
this for future work. In addition, the context network we considered in the study did not
perform cross-view reasoning, and we expect that networks utilizing all four standard views in
a mammogram exam can introduce more complete information and result in more reliable
cancer detection.
CONCLUSION
Besides performing breast-level classification, deep learning methods can help further reduce
unnecessary biopsies by classifying suspicious small regions as being benign or malignant.
Furthermore, incorporating global image context can improve the network’s ability to dis-
tinguish between localized benign and malignant lesions on high resolution images. Future
research on techniques for combining local information with global context may be promising
for breast cancer screening.
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